BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37299023)

  • 1. Synthesis and In Vitro Biological Evaluation of
    Braun S; Jelača S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
    Molecules; 2023 Jun; 28(11):. PubMed ID: 37299023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carborane-Based Tebufelone Analogs and Their Biological Evaluation In Vitro.
    Braun S; Paskaš S; Laube M; George S; Hofmann B; Lönnecke P; Steinhilber D; Pietzsch J; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
    ChemMedChem; 2023 Jul; 18(14):e202300206. PubMed ID: 37160667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carborane-Based Analogues of 5-Lipoxygenase Inhibitors Co-inhibit Heat Shock Protein 90 in HCT116 Cells.
    Kuhnert R; Sárosi MB; George S; Lönnecke P; Hofmann B; Steinhilber D; Steinmann S; Schneider-Stock R; Murganić B; Mijatović S; Maksimović-Ivanić D; Hey-Hawkins E
    ChemMedChem; 2019 Jan; 14(2):255-261. PubMed ID: 30471171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel di-tertiary-butyl phenylhydrazones as dual cyclooxygenase-2/5-lipoxygenase inhibitors: synthesis, COX/LOX inhibition, molecular modeling, and insights into their cytotoxicities.
    Ghatak S; Vyas A; Misra S; O'Brien P; Zambre A; Fresco VM; Markwald RR; Swamy KV; Afrasiabi Z; Choudhury A; Khetmalas M; Padhye S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):317-24. PubMed ID: 24295787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of acyclic triaryl (Z)-olefins possessing a 3,5-di-tert-butyl-4-hydroxyphenyl pharmacophore: dual inhibitors of cyclooxygenases and lipoxygenases.
    Moreau A; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Aug; 14(15):5340-50. PubMed ID: 16677817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CarbORev-5901: The First Carborane-Based Inhibitor of the 5-Lipoxygenase Pathway.
    Kuhnert R; Sárosi MB; George S; Lönnecke P; Hofmann B; Steinhilber D; Murganic B; Mijatovic S; Maksimovic-Ivanic D; Hey-Hawkins E
    ChemMedChem; 2017 Jul; 12(13):1081-1086. PubMed ID: 28569429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QSAR study of dual cyclooxygenase and 5-lipoxygenase inhibitors 2,6-di-tert-butylphenol derivatives.
    Ruiz J; Pérez C; Pouplana R
    Bioorg Med Chem; 2003 Sep; 11(19):4207-16. PubMed ID: 12951151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin.
    Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O
    Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydroxylamine analogs of 2,6-di-t-butylphenols: dual inhibitors of cyclooxygenase and 5-lipoxygenase or selective 5-lipoxygenase inhibitors.
    Kramer JB; Capiris T; Sircar JC; Connor DT; Bornemeier DA; Dyer RD; Kuipers PJ; Kennedy JA; Wright CD; Okonkwo GC
    Bioorg Med Chem; 1995 Apr; 3(4):403-10. PubMed ID: 8581424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells.
    Misra S; Ghatak S; Patil N; Dandawate P; Ambike V; Adsule S; Unni D; Venkateswara Swamy K; Padhye S
    Bioorg Med Chem; 2013 May; 21(9):2551-9. PubMed ID: 23517721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of transthyretin amyloidosis inhibitors containing carborane pharmacophores.
    Julius RL; Farha OK; Chiang J; Perry LJ; Hawthorne MF
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):4808-13. PubMed ID: 17360344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity.
    Useini L; Mojić M; Laube M; Lönnecke P; Mijatović S; Maksimović-Ivanić D; Pietzsch J; Hey-Hawkins E
    ChemMedChem; 2023 Mar; 18(5):e202200583. PubMed ID: 36583943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of polymorphonuclear leukocyte 5-lipoxygenase and platelet cyclooxygenase by alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), a new anti-inflammatory drug.
    Hidaka T; Takeo K; Hosoe K; Katsumi I; Yamashita T; Watanabe K
    Jpn J Pharmacol; 1985 Jul; 38(3):267-72. PubMed ID: 3932730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and structure-activity relationship of p-carborane-based non-secosteroidal vitamin D analogs.
    Fujii S; Kano A; Songkram C; Masuno H; Taoda Y; Kawachi E; Hirano T; Tanatani A; Kagechika H
    Bioorg Med Chem; 2014 Feb; 22(4):1227-35. PubMed ID: 24486205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipoxygenase Inhibitors as Cancer Chemopreventives: Discovery, Recent Developments and Future Perspectives.
    Mahboubi-Rabbani M; Zarghi A
    Curr Med Chem; 2021; 28(6):1143-1175. PubMed ID: 31820690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tebufelone (NE-11740), a new anti-inflammatory drug, on arachidonic acid metabolism.
    Weisman SM; Doyle MJ; Wehmeyer KR; Hynd BA; Eichhold TH; Clear RM; Coggeshall CW; Kuhlenbeck DL
    Agents Actions; 1994 May; 41(3-4):156-63. PubMed ID: 7942323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological properties of a new anti-inflammatory compound, alpha-(3,5-di-tert-butyl-4-hydroxybenzylidene)-gamma-butyrolacto ne (KME-4), and its inhibitory effects on prostaglandin synthetase and 5-lipoxygenase.
    Hidaka T; Hosoe K; Ariki Y; Takeo K; Yamashita T; Katsumi I; Kondo H; Yamashita K; Watanabe K
    Jpn J Pharmacol; 1984 Sep; 36(1):77-85. PubMed ID: 6438380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual synergistic inhibition of COX and LOX by potential chemicals from Indian daily spices investigated through detailed computational studies.
    Rudrapal M; Eltayeb WA; Rakshit G; El-Arabey AA; Khan J; Aldosari SM; Alshehri B; Abdalla M
    Sci Rep; 2023 May; 13(1):8656. PubMed ID: 37244921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inhibition of the arachidonic acid cascade by aza-2-aryl-1,4-naphthoquinone derivatives].
    Richwien A; Wurm G
    Pharmazie; 2004 Dec; 59(12):906-12. PubMed ID: 15638076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of a novel class of rofecoxib analogues as dual inhibitors of cyclooxygenases (COXs) and lipoxygenases (LOXs).
    Chen QH; Rao PN; Knaus EE
    Bioorg Med Chem; 2006 Dec; 14(23):7898-909. PubMed ID: 16904331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.